MA40990A - Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle - Google Patents

Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle

Info

Publication number
MA40990A
MA40990A MA040990A MA40990A MA40990A MA 40990 A MA40990 A MA 40990A MA 040990 A MA040990 A MA 040990A MA 40990 A MA40990 A MA 40990A MA 40990 A MA40990 A MA 40990A
Authority
MA
Morocco
Prior art keywords
dimethyl fumarate
formulations including
matrix formulations
including dimethyl
pharmaceutical matrix
Prior art date
Application number
MA040990A
Other languages
English (en)
French (fr)
Inventor
Shyam B Karki
Cheuk-Yui Leung
Yiqing Lin
Peter Zawaneh
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of MA40990A publication Critical patent/MA40990A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA040990A 2014-11-19 2015-11-18 Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle MA40990A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462081907P 2014-11-19 2014-11-19

Publications (1)

Publication Number Publication Date
MA40990A true MA40990A (fr) 2017-09-26

Family

ID=54838418

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040990A MA40990A (fr) 2014-11-19 2015-11-18 Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle

Country Status (13)

Country Link
US (2) US20190083404A1 (enExample)
EP (1) EP3220897A1 (enExample)
JP (2) JP6901393B2 (enExample)
KR (1) KR20170086053A (enExample)
CN (2) CN113262205A (enExample)
AU (2) AU2015349891B2 (enExample)
CA (1) CA2967645A1 (enExample)
EA (1) EA201791089A1 (enExample)
HK (1) HK1244215A1 (enExample)
IL (1) IL252105A0 (enExample)
MA (1) MA40990A (enExample)
MX (1) MX391400B (enExample)
WO (1) WO2016081671A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2987895A1 (en) 2015-06-01 2016-12-08 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
KR102714380B1 (ko) 2021-06-09 2024-10-11 강원대학교산학협력단 경구 투여용 나노입자 및 이의 제조방법
WO2023036702A1 (en) 2021-09-09 2023-03-16 It Pharmagus Limited Method for the manufacturing of a solid body as an oral dosage form of a pharmaceutical or a food supplement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1207866E (pt) * 1999-08-31 2005-02-28 Gruenenthal Gmbh Forma de administracao retardada contendo sacarinato de tramadol
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
CN109044985A (zh) * 2009-01-09 2018-12-21 前进制药知识产权有限公司 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂
NZ617130A (en) * 2009-04-29 2015-06-26 Biogen Ma Inc Treatment of neurodegeneration and neuroinflammation
CA2827990A1 (en) * 2011-02-25 2012-08-30 The Johns Hopkins University Chalcone derivatives as nrf2 activators
US20130158077A1 (en) * 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
AU2013203445C1 (en) * 2012-02-07 2017-04-20 Biogen Ma Inc. Pharmaceutical compositions containing dimethyl fumarate
AU2013305684B2 (en) * 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
EP3566701A1 (en) * 2012-12-21 2019-11-13 Biogen MA Inc. Deuterium substituted fumarate derivatives
CN105369562B (zh) * 2014-08-28 2019-12-20 青岛海尔洗衣机有限公司 一种带有防衣物褪色提醒功能的洗衣机

Also Published As

Publication number Publication date
AU2021204247A1 (en) 2021-07-22
CA2967645A1 (en) 2016-05-26
EA201791089A1 (ru) 2017-11-30
JP2017534667A (ja) 2017-11-24
MX2017006561A (es) 2018-02-21
MX391400B (es) 2025-03-21
KR20170086053A (ko) 2017-07-25
IL252105A0 (en) 2017-07-31
CN107205942A (zh) 2017-09-26
HK1244215A1 (zh) 2018-08-03
US20190175510A1 (en) 2019-06-13
JP2021152046A (ja) 2021-09-30
CN113262205A (zh) 2021-08-17
US20190083404A1 (en) 2019-03-21
AU2015349891B2 (en) 2021-04-01
JP6901393B2 (ja) 2021-07-14
EP3220897A1 (en) 2017-09-27
AU2015349891A1 (en) 2017-05-25
WO2016081671A1 (en) 2016-05-26
WO2016081671A8 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
EP3407202A4 (en) Matrix calculation apparatus
PT4070788T (pt) Formulações farmacêuticas
HUE054344T2 (hu) Gyógyászati készítmények AZD9291 tartalommal
MA42844A (fr) Combinaisons thérapeutiques comprenant des immunoconjugués anti-folr1
EP3493798A4 (en) CANNABIS
EP3454899C0 (en) PHARMACEUTICAL COMPOSITION
MA42303A (fr) Formulations pharmaceutiques
DK3199161T3 (da) Farmaceutisk præparat
HRP20180641T1 (hr) Pirolidinski gpr40 modulatori za liječenje bolesti kao što je dijabetes
DK3634377T3 (da) Farmaceutisk formulering
EP3300502A4 (en) PROCESS FOR PREPARING VITAMIN A OLIGOSACCHARIDES AND METHOD FOR THE PRODUCTION THEREOF
DK3348260T3 (da) Farmaceutisk tramadol-sammensætning til oftalmisk anvendelse
EP3603642A4 (en) PHARMACEUTICAL PREPARATION
HUE050779T2 (hu) Folyékony gyógyszerészeti készítmény
MA40982A (fr) Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
EP3561593A4 (en) PROJECTION DISPLAY SYSTEM
EP3383371A4 (en) PHARMACEUTICAL FORMULATION
DK3280447T3 (da) Farmaceutiske formuleringer
EP3646866A4 (en) PHARMACEUTICAL PREPARATION
EP3389633A4 (en) Pharmaceutical compositions comprising phenylaminopyrimidine derivative
MA49822A (fr) Combinaison pharmaceutique comprenant du ponesimod
DK2992967T3 (da) Medikamentdispenser
CL2016002705A1 (es) Formulación agroquímica
EP3337463A4 (en) PHARMACEUTICAL FORMULATIONS
HUE053974T2 (hu) Szemészeti gyógyászati készítmény